These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22965687)

  • 1. High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.
    Zhang Y; Tan YF; Jiang C; Zhang K; Zha TZ; Zhang M
    Pathol Oncol Res; 2013 Jan; 19(1):79-88. PubMed ID: 22965687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.
    Zhou Y; Zhou N; Fang W; Huo J
    Diagn Pathol; 2010 Sep; 5():58. PubMed ID: 20846397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.
    Zha TZ; Hu BS; Yu HF; Tan YF; Zhang Y; Zhang K
    Tumour Biol; 2012 Dec; 33(6):2125-34. PubMed ID: 22864671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of ADAM8 and its clinical values in diagnosis and prognosis of hepatocellular carcinoma.
    Jiang C; Zhang Y; Yu HF; Yu XT; Zhou SJ; Tan YF
    Tumour Biol; 2012 Dec; 33(6):2167-72. PubMed ID: 22941466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression levels of the metalloproteinase ADAM8 critically regulate proliferation, migration and malignant signalling events in hepatoma cells.
    Awan T; Babendreyer A; Mahmood Alvi A; Düsterhöft S; Lambertz D; Bartsch JW; Liedtke C; Ludwig A
    J Cell Mol Med; 2021 Feb; 25(4):1982-1999. PubMed ID: 33314720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of ADAM8 correlates with poor prognosis in hepatocellular carcinoma.
    Zhang Y; Zha TZ; Hu BS; Jiang C; Ge ZJ; Zhang K; Tan YF
    Surgeon; 2013 Apr; 11(2):67-71. PubMed ID: 22878099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
    Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
    Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
    Yuan S; Lei S; Wu S
    Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication Protein A 3 Is Associated with Hepatocellular Carcinoma Tumorigenesis and Poor Patient Survival.
    Xiao W; Zheng J; Zhou B; Pan L
    Dig Dis; 2018; 36(1):26-32. PubMed ID: 28683444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.
    Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T
    Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane protein 106C promotes the development of hepatocellular carcinoma.
    Luo X; Han G; Lu R; Guan S; Wang Y; Ju L; Chen L; Shao J; Bian Z
    J Cell Biochem; 2020 Nov; 121(11):4484-4495. PubMed ID: 32037603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of a disintegrin and metalloproteinase 21 is associated with motility, metastasis, and poor prognosis in hepatocellular carcinoma.
    Honda H; Takamura M; Yamagiwa S; Genda T; Horigome R; Kimura N; Setsu T; Tominaga K; Kamimura H; Matsuda Y; Wakai T; Aoyagi Y; Terai S
    Sci Rep; 2017 Nov; 7(1):15485. PubMed ID: 29138461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
    Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
    Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
    Qin AD; Liu XX; Li J; Liu J; Li YS
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
    [No Abstract]   [Full Text] [Related]  

  • 18. The important role of ADAM8 in the progression of hepatocellular carcinoma induced by diethylnitrosamine in mice.
    Li SQ; Wang DM; Zhu S; Ma Z; Li RF; Xu ZS; Han HM
    Hum Exp Toxicol; 2015 Nov; 34(11):1053-72. PubMed ID: 25585999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo.
    Bai Y; Wang J; Han J; Xie XL; Ji CG; Yin J; Chen L; Wang CK; Jiang XY; Qi W; Jiang HQ
    Mol Carcinog; 2017 Mar; 56(3):1137-1149. PubMed ID: 27770580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.